Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 11.89 AUD -0.42% Market Closed
Market Cap: 4B AUD

Relative Value

The Relative Value of one TLX stock under the Base Case scenario is hidden AUD. Compared to the current market price of 11.89 AUD, Telix Pharmaceuticals Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
39
Median 3Y
12.8
Median 5Y
20.6
Industry
7.9
Forward
4.9
vs History
19
vs Industry
1
Median 3Y
211.4
Median 5Y
-16.3
Industry
23.7
Forward
-1 188
vs History
55
vs Industry
1
Median 3Y
243.5
Median 5Y
210.7
Industry
22
vs History
57
vs Industry
10
Median 3Y
22.6
Median 5Y
16.8
Industry
24.3
vs History
96
vs Industry
5
Median 3Y
25.9
Median 5Y
25.9
Industry
3.3
vs History
98
vs Industry
33
Median 3Y
12.6
Median 5Y
19.6
Industry
8.2
Forward
5.1
vs History
98
vs Industry
26
Median 3Y
21.4
Median 5Y
33.1
Industry
10.2
vs History
26
vs Industry
1
Median 3Y
147.2
Median 5Y
-16.8
Industry
6.1
Forward
95.6
vs History
26
vs Industry
1
Median 3Y
147.2
Median 5Y
-16.8
Industry
6.5
Forward
167.1
vs History
52
vs Industry
1
Median 3Y
240.4
Median 5Y
203.8
Industry
7.9
vs History
vs Industry
0
Median 3Y
-21.7
Median 5Y
-20.8
Industry
6.3
vs History
98
vs Industry
16
Median 3Y
19
Median 5Y
18.6
Industry
5.7

Multiples Across Competitors

TLX Competitors Multiples
Telix Pharmaceuticals Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Telix Pharmaceuticals Ltd
ASX:TLX
4B AUD 6.1 370.8 150.6 150.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 667 065.8 -160 014.6 -194 308.7 -192 091.4
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 092.5 -534 -581.4 -565.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.2 59.8
P/E Multiple
Earnings Growth PEG
AU
Telix Pharmaceuticals Ltd
ASX:TLX
Average P/E: 211.4
370.8
26%
14.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 014.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Telix Pharmaceuticals Ltd
ASX:TLX
Average EV/EBITDA: 52.6
150.6
31%
4.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 308.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Telix Pharmaceuticals Ltd
ASX:TLX
Average EV/EBIT: 58.1
150.6
33%
4.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 091.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A